Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

WIB-CT discussion highlights diversity best practices

Executive Women in Bio-CT recently held a panel discussion on Diversity, Equity, and Inclusion (DE&I) Initiatives in Action, with panelists discussing the ways their organizations have...

| By Kelley Gipson

Sema4 turned quickly to respond to COVID-19

It was April of 2020. The state was desperate for help from any laboratory that could process COVID tests quickly. Much of the laboratory space...

| By Kelley Gipson

Artizan, Biohaven join forces against Parkinson’s

Artizan Biosciences and Biohaven Therapeutics report they will be working together to find treatments for Parkinson’s disease. The two New Haven-based companies indicated they will be using recent scientific...

| By Kelley Gipson

Hyperfine to offer new version of portable MRI

The FDA has approved a new “deep-learning” version of Hyperfine’s portable MRI machine, the Guilford-based company reports. Deep learning (DL), a type of machine learning...

| By Kelley Gipson

Stamford’s Cara in top-15 of Deloitte’s Fast 500

Stamford-based Cara Therapeutics, which recently gained federal approval for its first drug, ranks No. 14 in professional-services firm Deloitte’s latest standings of the fastest-growing technology firms...

| By Kelley Gipson

Astrocyte publishes results re stroke treatment

Astrocyte Pharmaceuticals reports the publication of a manuscript in the peer reviewed journal Stroke entitled: Adenosine A1R/A3R (Adenosine A1 and A3 Receptor) Agonist AST-004 Reduces Brain...

| By Kelley Gipson

CooperSurgical to acquire fertility company

Trumbull-based CooperSurgical says it has reached an agreement to acquire a fertility company, Generate Life Sciences, for $1.6 billion. Generate Life Sciences, based in California, provides donor...

| By Kelley Gipson

Biden says U.S. to buy Pfizer’s COVID-19 pill

President Biden announced the United States is buying 10 million courses of Pfizer’s Covid-19 treatment pill, in a $5.3 billion deal the President said is...

| By Kelley Gipson

SPRINT program to offer life science internships

The New Haven Region’s bioscience companies are joining together to launch the SPRINT (Student Program to Ready Interns for Next-generation Talent) internship program. The goal...